Sonal Munsiff

Associate Professor, Director OPAT program

University of Rochester

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sonal Munsiff is an Associate Professor and the Director of the OPAT program at the University of Rochester, USA. Her research focuses on outpatient parenteral antimicrobial therapy, tuberculosis treatment guidelines, and the epidemiology of ocular tuberculosis. Recent articles include studies on the quantification of nonbillable workloads in OPAT programs and the impact of various treatments on infectious diseases.

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Collaborators (5)

Tetsuro Maeda

Assistant Professor

The University of Alabama

UNITED STATES

View details

Raquel Duarte3,8,9,10

PORTUGAL

View details

Yohei Doi

Professor and Chair

Fujita Health University

JAPAN

View details

Ibrahim Abubakar

Dean

University College London

UNITED KINGDOM

View details

Manoj Mammen

Associate Professor

University of Rochester

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sonal Munsiff

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

Quantifying and Financing the Nonbillable Workload of Outpatient Parenteral Antimicrobial Therapy (OPAT)—A Model for Assessing and Supporting Staffing Needs for OPAT Programs

Effect of Pitavastatin on Epigenetic Aging Biomarkers in People With HIV: Pilot Substudy of the REPRIEVE Trial

American Thoracic Society/Centers for Disease Control and Prevention/European Respiratory Society/Infectious Diseases Society of America (ATS/CDC/ERS/IDSA) Updated Guideline on the Treatment of Tuberculosis

Assessing Infectiousness and the Impact of Effective Treatment to Guide Isolation Recommendations for People With Pulmonary Tuberculosis

Making the EHR Work for You—Modifications of an Electronic Health Record System to Improve Tracking and Management of Patients Receiving Outpatient Parenteral Antibiotic Therapy

Tuberculosis screening for patients on biologic Medications: A Single-Center experience and Society guideline Review, Monroe County, New York, 2018–2021

Epidemiology and Clinical Characteristics of Ocular Tuberculosis in the United States, 1993–2019

Cost evaluation of continuation of therapy with dalbavancin compared to standard-of-care antibiotics alone in hospitalized persons who inject drugs with severe gram-positive infections

Daily fosfomycin versus levofloxacin for complicated urinary tract infections

A Case of Multiple Skin Lesions After LipodissolveTM Injection

Collaborators (5)

Tetsuro Maeda

Raquel Duarte3,8,9,10

Yohei Doi

Ibrahim Abubakar

Manoj Mammen

Make your next move.